Clinical Trial Update: A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating mFOLFOX6 plus either tivozanib or bevacizumab as first-line therapy for metastatic colorectal cancer has completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• MFOLFOX6
• Tivozanib (tivozanib)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-03